Medtronic (MDT) Q2 2025 Earnings Call Transcript
Medtronic (NYSE: MDT) Q2 2025 Earnings Call Nov 19, 2024, 8:00 a.m. ET ...
360dx10h
'On Vivo' and 'In Vivo' Wearable Diagnostics Advancing to Clinical Use
Wearable diagnostics are poised to transform subjective, episodic measures of disease progression to quantified, continuous data streams, according to some industry experts.
Medtronic Q3 Earnings: A Solid Performance, But Bottom Line Still Needs Fixing
Medtronic plc's Q2 earnings show moderate growth, highlighting potential for shareholder value through strategic initiatives. Click for my MDT earnings update.
DexCom Pairs Its Glucose Monitor With Oura’s Smart Ring
If you want to monitor your vital signs like an Olympic athlete, you should welcome a pact between glucose-monitor vendor ...
Your Oura Ring will be able to show you glucose readings in 2025 – thanks to Dexcom integration
In 2025 the Oura Ring will integrate with Dexcom glucose sensors Dexcom data will sit alongside other health points within ...
Fierce Healthcare21h
Smart ring maker Oura picks up $75M series D, inks strategic partnership with Dexcom
Oura is partnering with medical device maker Dexcom to integrate data from glucose biosensors with the Oura Ring, which ...
Oura valued at $5B following deal with medical device firm Dexcom
Smart ring maker Oura announced on Tuesday that it has received a $75 million investment from glucose device maker Dexcom.
Oura Valued at $5 Billion in Deal With Glucose Device Maker Dexcom
Smart ring maker Oura Health Oy is getting a $75 million investment from medical device firm Dexcom Inc., setting the stage for the two companies to share data and cross-sell products.